Profile
12.42
-0.01
(-0.08%)
07/17/2026
COMPASS Pathways plc (CMPS)Profile
Stock Exchange
United States (NASDAQ)
Sector
Healthcare
Industry
Medical - Care Facilities
Type
ADR
CEO
Kabir Kumar Nath
Website
First Price Date
2020-09-18
Last Price Date
2026-07-17
About
Long Description
COMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States. Established in 2020 and headquartered in London, UK, the firm focuses on developing novel treatments. Its key product is COMP360, an investigational psilocybin therapy. This therapy has advanced through Phase IIb clinical trials for treatment-resistant depression and is currently undergoing Phase II trials for post-traumatic stress disorder. The company previously operated under the name COMPASS Rx Limited before rebranding to COMPASS Pathways plc in August 2020.